Emera Incorporated

Emera Incorporated

18.63
USD
+5.86
(+45.88%)
Feb 16Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
2,230
2,939
2,789
4,277
6,226
6,524
6,111
5,506
5,765
7,588
7,563
7,200
8,776
8,814
Operating Margin (%)
18.25
22.71
18.21
12.98
22.78
21.43
22.53
21.29
16.13
22.43
23.72
18.13
23.36
22.41
Depreciation Expense
314
342
352
593
851
928
911
899
915
959
1,060
1,165
1,298
1,336
Net Income, GAAP
237
433
427
255
294
746
708
983
560
1,008
1,044
567
1,089
996
Effective Tax Rate (%)
14.5
20.06
17.06
- -
63.49
8.46
7.91
25.74
- -
15.49
10.91
- -
6.92
8.79
Profit Margin (%)
10.62
14.73
15.31
5.96
4.72
11.43
11.59
17.85
9.71
13.28
13.8
7.88
12.41
11.3
Working Capital
-369
288
1,229
-1,213
-1,420
-1,721
-1,680
-2,697
-1,742
-2,391
-836
-1,427
-2,238
-1,626
LT Debt
3,364
3,660
4,416
14,268
13,140
14,292
13,679
12,339
14,196
15,744
17,689
18,173
18,453
19,126
Total Equity
2,897
3,705
4,334
6,816
7,204
8,358
8,601
9,238
10,150
11,441
12,088
13,291
13,396
14,361
Return on Invested Capital (%)
5.33
7.2
5.02
- -
2.31
5.41
5.02
3.48
- -
4.82
5.12
- -
5.41
5.14
Return on Capital (%)
5.92
7.64
6.96
- -
2.43
5.91
5.62
6.08
- -
5.63
6.02
- -
5.99
5.58
Return on Common Equity (%)
11.59
17
12.85
4.79
4.29
10.35
8.91
11.9
6.04
10.11
9.47
4.39
8.52
7.34

Capital Structure

CAD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
2,751
2,574
2,459
LT Borrowings
21,206
19,543
19,126
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
1,422
1,422
1,422
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
- -

Working Capital

CAD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
6,586
4,181
4,471
Cash, Cash Equivalents & STI
2,457
396
600
Accounts Receivable, Net
1,110
1,069
976
Inventories
806
823
859
Total Current Liabilities
6,176
5,723
6,097
Payables & Accruals
1,674
1,690
1,766
ST Debt
2,751
2,574
2,459
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.83%
7.8%
0.79%
Free Cash Flow
139.67%
43.78%
242.57%
Net Income, GAAP
24.94%
17.38%
92.06%
Sales/Revenue/Turnover
14.06%
10.62%
21.89%
Total Cash Common Dividend
13.99%
7.11%
7.06%

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,018
1,617
1,802
1,763
7,200
2025
2,676
1,988
2,106
2,006
8,776
2026
2,813
2,011
1,984
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Scott Carlyle Balfour
Full Time Employees
7,800
Sector
Utilities
Industry
Electric utilities
Address
1223 Lower Water Street Halifax NS Canada B3J 3S8
IPO Date
Aug 12, 1992
Website
emera.com
Business
Emera Incorporated is a diversified energy and services enterprise, headquartered in Halifax, Canada, engaged in the generation, transmission, and distribution of electricity for a broad customer base. Established in 1998, the company operates across distinct segments including Florida Electric Utility, Canadian Electric Utilities, Other Electric Utilities, Gas Utilities and Infrastructure, and other related activities. Emera's operations encompass a varied electricity generation portfolio, utilizing sources such as natural gas, coal, hydro, wind, solar, oil, and biomass. The company delivers essential energy to approximately 2.6 million utility customers throughout Canada, the United States, and the Caribbean. Its electric utilities serve around 840,000 customers in West Central Florida, 500,000 in Nova Scotia, and 227,000 customers across the Caribbean islands including Barbados, Grand Bahama, Dominica, and St. Lucia. The Gas Utilities and Infrastructure segment provides services to approximately 470,000 customers in Florida, with the New Mexico Gas Company, serving 540,000 customers, currently under an agreement for sale expected to finalize in 2025. Additionally, Emera is involved in the transportation of natural gas, notably through its Brunswick Pipeline, and offers energy marketing, trading, and asset management services. With a strategic focus on transitioning from high-carbon to low-carbon energy, Emera has set a vision for net-zero CO2 emissions by 2050, aiming for a 55% reduction by the end of 2025 and an 80% reduction by 2040, compared to 2005 levels. This commitment is supported by a substantial $20 billion five-year capital plan through 2029, primarily dedicated to investments in grid reliability, modernization, and growth, with a significant portion allocated to Florida operations. Recent initiatives include expanding solar capacity at Tampa Electric and developing battery storage projects at Nova Scotia Power.

Company News

  • Emera Q3 Earnings Call Highlights

  • Vir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta

  • Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data

  • Emera Reports 2026 Third Quarter Financial Results and Unveils $21.5 Billion Five-Year Capital Plan

  • Crossmark Global Holdings Inc. Buys 21,825 Shares of eMagin Corporation $EMA

  • Pfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting

  • SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

  • Emera Incorporated (EMA.TO) – What Are Researchers Saying About This Stock?

  • Emera Declares Quarterly Dividends

  • Emera Teleconference on November 6 to Discuss Q3 2026 Results and 2027-2031 Capital Plan

  • Emera (NYSE: EMA) agrees $72 billion merger with Canadian Utilities and ATCO spin-off

  • Emera to combine with Canadian Utilities in largest all-Canadian merger on record

  • Canadian Utilities, Emera Strike C$72B Utility Merger Deal

  • Emera, Canadian Utilities Unveil C$72B Merger to Create Utility Powerhouse

  • Emera, Canadian Utilities Unveil C$72B Merger to Create Utility Powerhouse

  • Emera, ATCO and Canadian Utilities Announce Transformational Agreement to Create Canadian Utility and Energy Infrastructure Powerhouse

  • Emera Announces Increase in Common Dividend

  • Emera Incorporated (TSE:EMA) Given Consensus Rating of “Moderate Buy” by Brokerages

  • Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform

  • Engineers Gate Manager LP Purchases 17,165 Shares of eMagin Corporation $EMA